Late-Breaking MagSense® Safety Study Abstract Accepted for AACR 2018
March 14, 2018
Imagion Biosystems’ abstract “Detection of HER2+ tumor cells using MagSense® nanoparticles: safety and sensitivity” has been accepted for the 2018 AACR meeting under the organization’s